Safety, risks, and red flags

Most events reported in studies are local and mild: pain, swelling, and bruising at the liposuction or injection site, usually resolving within days to weeks.

Serious events are uncommon but documented: infection, fat necrosis, thromboembolism, and — when injected into high-risk sites such as periocular tissue or vessels — severe complications including vision loss.

Obtaining SVF requires liposuction, a procedure with its own risks relating to anaesthesia, blood loss, and infection.

Processing quality, laboratory sterility, and team experience materially change the risk profile.

In many countries SVF is a regulated product, permitted mainly in research settings or narrow indications — not as general standard care.

Marketing that claims to treat many diseases at once typically conflicts with both regulation and the available evidence.

Guaranteed results, talk of a cure, no written risk disclosure, no named responsible physician, payment pressure, or before-after photos used as the main evidence are all red flags.

Questions to ask: which studies support this, at what evidence level, who performs the procedure, how is follow-up done, and what is the plan if complications occur.